Moleculin Biotech, Inc. Operating Lease Right-of-Use Assets
Moleculin Biotech, Inc. (MBRX) had Operating Lease Right-of-Use Assets of $254.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $254.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $284.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $314.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $343.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $254.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $284.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $314.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $343.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $370.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $398.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $424.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $450.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $475.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $500.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $524.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $547.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $358.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $381.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $403.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $425.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $446.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $81.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $107.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $131.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $155.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $179.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $202.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $224.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $245.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $266.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $287.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $306.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $103.00K 10-Q · filed 2019-08-16 |
| 2019-03-31 | $106.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |